Florida, December 27, 2017: The Global Injectable Drug Delivery Market is expected to exceed more than US$ 624.5 Billion by 2022 at a CAGR of 11.5% in the given forecast period.

    Creating delivery devices for injectable drugs has been one of the Challenging task of today. As great number of innovation oriented advancements have occurred in the biologics market, which additionally increases the applicability of the injectable devices in the complex disease areas. The expansion in number of chronic illnesses like diabetes and cancer has increased the requirement for Injectable drugs delivery. Unlike other conventional methods of drug delivery, injectable allow maximum bioavailability of the pharmaceutical drug as it bypasses the first pass metabolism. With considerable development in mechanical headways, the devices being produced and marketed in order to take into account the particular needs of the patients.

    This report provides:

    1) An overview of the global market for Global Injectable Drug Delivery Market and related technologies.
    2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
    3) Identifications of new market opportunities and targeted promotional plans for Global Injectable Drug Delivery Market.
    4) Discussion of research and development, and the demand for new products and new applications.
    5) Comprehensive company profiles of major players in the industry.

    You Can Find Full Report: https://www.marketresearchengine.com/injectable-drug-delivery-market

    The major driving factors of Global Injectable Drug Delivery Market are as follows:

    • Escalation in demand for self- injection devices
    • Increase in number of chronic diseases
    • Biosimilars
    • New Product Launches and Technological Advancements
    • Innovative technological progress
    • Development of the biologics market

    The restraining factors of Global Injectable Drug Delivery Market are as follows:

    • Needle stick injuries and infections
    • Product recalls
    • Optional mode of drug delivery

    The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Baxter International (U.S.), Pfizer (U.S.), Gerresheimer AG (Germany), Becton, Dickinson and Company (U.S.), Schott AG (Germany), Eli Lilly and Company (U.S.), and Terumo Corporation (Japan). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

    Request Sample Report here @: https://www.marketresearchengine.com/injectable-drug-delivery-market

     

    Table of Contents

    1 INTRODUCTION

    2 Research Methodology

    3 Executive Summary

    4 Premium Insights

    5 Market Overview

    6 Regulatory Scenario

    7 Injectable Drug Delivery Market, By Type

    7.1 Introduction
    7.2 Devices
    7.2.1 Conventional Injection Devices
    7.2.1.1 By Material
    7.2.1.1.1 Glass
    7.2.1.1.2 Plastic
    7.2.1.2 By Product
    7.2.1.2.1 Fillable Syringes
    7.2.1.2.2 Prefilled Syringes
    7.2.1.3 By Usability
    7.2.1.3.1 Reusable Injection Devices
    7.2.1.3.2 Disposable Injection Devices
    7.2.2 Self-Injection Devices
    7.2.2.1 Needle-Free Injectors
    7.2.2.1.1 By Product
    7.2.2.1.1.1 Fillable Needle-Free Injectors
    7.2.2.1.1.2 Prefilled Needle-Free Injectors
    7.2.2.1.2 By Technology
    7.2.2.1.2.1 Jet-Based Needle-Free Injectors
    7.2.2.1.2.2 Spring-Based Needle-Free Injectors
    7.2.2.1.2.3 Laser-Powered Needle-Free Injectors
    7.2.2.1.2.4 Vibration-Based Needle-Free Injectors
    7.2.2.1.3 By Usability
    7.2.2.1.3.1 Reusable Needle-Free Injectors
    7.2.2.1.3.2 Disposable Needle-Free Injectors
    7.2.2.2 Autoinjectors
    7.2.2.2.1 By Product
    7.2.2.2.1.1 Fillable Autoinjectors
    7.2.2.2.1.2 Prefilled Autoinjectors
    7.2.2.2.2 By Technology
    7.2.2.2.2.1 Automated Autoinjectors
    7.2.2.2.2.2 Manual Autoinjectors
    7.2.2.2.3 By Design
    7.2.2.2.3.1 Standardized Autoinjectors
    7.2.2.2.3.2 Customized Autoinjectors
    7.2.2.2.4 By Usability
    7.2.2.2.4.1 Reusable Autoinjectors
    7.2.2.2.4.2 Disposable Autoinjectors
    7.2.2.3 Pen Injectors
    7.2.2.3.1 By Product
    7.2.2.3.1.1 Single-Chambered Pen Injectors
    7.2.2.3.1.2 Dual-Chambered Pen Injectors
    7.2.2.3.2 By Design
    7.2.2.3.2.1 Standard Pen Injectors
    7.2.2.3.2.2 Customized Pen Injectors
    7.2.2.3.3 By Usability
    7.2.2.3.3.1 Reusable Pen Injectors
    7.2.2.3.3.2 Disposable Pen Injectors
    7.2.2.4 Wearable Injectors
    7.2.2.5 Other Devices
    7.3 Formulations
    7.3.1 Conventional Drug Delivery Formulations
    7.3.1.1 Solutions
    7.3.1.2 Reconstituted/Lyophilized Formulations
    7.3.1.3 Suspensions
    7.3.1.4 Emulsions
    7.3.2 Novel Drug Delivery Formulations
    7.3.2.1 Colloidal Dispersions
    7.3.2.1.1 Niosomes
    7.3.2.1.2 Liposomes
    7.3.2.1.3 Polymeric/Mixed Micelles
    7.3.2.1.4 Nanoparticles
    7.3.2.1.4.1 Solid-Lipid Nanoparticles
    7.3.2.1.4.2 Nanosuspensions
    7.3.2.1.4.3 Nanoemulsions
    7.3.2.2 Microparticles
    7.3.2.2.1 Microspheres
    7.3.2.2.2 Microcapsules
    7.3.3 Long-Acting Injection Formulations

    8 Injectable Drug Delivery Market, By Formulation Packaging

    9 Injectable Drug Delivery Market, By Therapeutic Application

    10 Injectable Drug Delivery Market, By Usage Pattern

    11 Injectable Drug Delivery Market, By Site of Administration

    12 Injectable Drug Delivery Market, By Distribution Channel

    13 Injectable Drug Delivery Market, By Facility of Use

    14 Injectable Drug Delivery Market, By Region

    15 Competitive Landscape

    16 Company Profiles

    16.1 Introduction

    16.2 Baxter International, Inc.

    16.3 Becton, Dickinson and Company

    16.4 Gerresheimer AG

    16.5 Pfizer, Inc.

    16.6 Schott AG

    16.7 ELI Lilly and Company

    16.8 Sandoz (A Division of Novartis AG)

    16.9 Terumo Corporation

    16.10 Teva Pharmaceutical Industries Ltd.

     

    Media Contact

    Company Name: Market Research Engine

    Contact Person: John Bay

    Email: john@marketresearchengine.com

    Phone: +1-855-984-1862

    Country: United States

    Website: https://www.marketresearchengine.com/

     

     

    Source: http://www.financeswire.com/global-injectable-drug-delivery-market-size-will-exceed-us-624-5-billion-by-2022